OLEMA PHARMACEUTICALS
Н/д
31-декабря-69 19:00:00
15 мин. задержка
Акции
Н/д
Сегодняшний диапазон
Н/д - Н/д
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Olema Oncology Nominates OP-3136, an Orally Bioavailable KAT6 Inhibitor, as a Development Candidate
08 янв 2024 08:12:48 Источник Nasdaq GlobeNewswire
-
Olema Oncology to Present at 42nd Annual J.P. Morgan Healthcare Conference
02 янв 2024 16:01:00 Источник Nasdaq GlobeNewswire
-
05 дек 2023 12:27:48 Источник Nasdaq GlobeNewswire
-
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 дек 2023 16:29:00 Источник Nasdaq GlobeNewswire
-
28 ноя 2023 17:10:00 Источник Nasdaq GlobeNewswire
-
Olema Oncology Reports Third Quarter 2023 Financial Results and Provides Corporate Update
07 ноя 2023 16:02:00 Источник Nasdaq GlobeNewswire
-
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02 ноя 2023 16:32:00 Источник Nasdaq GlobeNewswire
-
Olema Oncology to Participate in Upcoming Investor Conferences in November
01 ноя 2023 16:27:00 Источник Nasdaq GlobeNewswire
-
Olema Oncology Announces Positive Phase 2 Monotherapy Clinical Study Results for Palazestrant
22 окт 2023 02:55:00 Источник Nasdaq GlobeNewswire
-
Olema Oncology Appoints Oncology Biotech Executive Scott Garland to Board of Directors
17 окт 2023 07:01:00 Источник Nasdaq GlobeNewswire
-
16 окт 2023 07:02:00 Источник Nasdaq GlobeNewswire
-
Olema Oncology KAT6 Inhibitor Compounds Demonstrate Potent Anti-Tumor Activity
12 окт 2023 07:01:00 Источник Nasdaq GlobeNewswire
-
Olema Oncology Announces Expansion of Collaboration Agreement with Novartis
10 окт 2023 07:00:00 Источник Nasdaq GlobeNewswire
-
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 окт 2023 16:30:00 Источник Nasdaq GlobeNewswire
-
20 сен 2023 07:29:20 Источник Nasdaq GlobeNewswire
-
Olema Oncology to Participate in Upcoming Investor Conferences
06 сен 2023 16:30:55 Источник Nasdaq GlobeNewswire
-
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 сен 2023 16:30:00 Источник Nasdaq GlobeNewswire
-
Olema Oncology Announces Combined Financing for Up to $180 Million
05 сен 2023 07:30:49 Источник Nasdaq GlobeNewswire
-
Olema Oncology Reports Second Quarter 2023 Financial Results and Provides Corporate Update
08 авг 2023 16:03:07 Источник Nasdaq GlobeNewswire
-
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02 авг 2023 16:30:34 Источник Nasdaq GlobeNewswire